Selective serotonin reuptake inhibitors (SSRIs) prevent meta-iodobenzylguanidine (MIBG) uptake in platelets without affecting neuroblastoma tumor uptake
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2191-219X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Selective serotonin reuptake inhibitors (SSRIs) prevent meta-iodobenzylguanidine (MIBG) uptake in platelets without affecting neuroblastoma tumor uptake ; volume:10 ; number:1 ; day:8 ; month:7 ; year:2020 ; pages:1-12 ; date:12.2020
EJNMMI Research ; 10, Heft 1 (8.7.2020), 1-12, 12.2020
- Creator
-
Blom, Thomas
Meinsma, Rutger
Rutgers, Marja
Buitenhuis, Corine
Dekken-Van den Burg, Marieke
Kuilenburg, André B. P. van
Tytgat, Godelieve A. M.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13550-020-00662-w
- URN
-
urn:nbn:de:101:1-2020090621360933724817
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Blom, Thomas
- Meinsma, Rutger
- Rutgers, Marja
- Buitenhuis, Corine
- Dekken-Van den Burg, Marieke
- Kuilenburg, André B. P. van
- Tytgat, Godelieve A. M.
- SpringerLink (Online service)
Other Objects (12)
123I metaiodobenzylguanidine (MIBG) uptake predicts early relapse of neuroblastoma using semi-quantitative SPECT/CT analysis
Thrombocytopenia after meta-iodobenzylguanidine (MIBG) therapy in neuroblastoma patients may be caused by selective MIBG uptake via the serotonin transporter located on megakaryocytes
Laquinimod ameliorates excitotoxic damage by regulating glutamate re-uptake
Neuroblastoma : mIBG in its diagnosis and management
Selective serotonin re-uptake inhibitor sertraline inhibits bone healing in a calvarial defect model
MYCN-driven fatty acid uptake is a metabolic vulnerability in neuroblastoma
Selective serotonin re-uptake inhibitors and the risk of violent suicide: a nationwide postmortem study
LRP8‐mediated selenocysteine uptake is a targetable vulnerability in MYCN‐amplified neuroblastoma
A sexually dimorphic hepatic cycle of periportal VLDL generation and subsequent pericentral VLDLR-mediated re-uptake
Bilateral adrenal uptake of 123I MIBG scintigraphy with mild catecholamine elevation, the diagnostic dilemma, and its characteristics
Molecular studies of ligand binding properties and re-uptake mechanisms at the human and murine serotonin transporter
Myokardialer I-123-Metajodbenzylguanidin (MIBG) Uptake als Zeichen der sympathischen Reinnervation nach Herztransplantation : eine Doppelnuklidstudie mit Thallium-201
123I metaiodobenzylguanidine (MIBG) uptake predicts early relapse of neuroblastoma using semi-quantitative SPECT/CT analysis
Thrombocytopenia after meta-iodobenzylguanidine (MIBG) therapy in neuroblastoma patients may be caused by selective MIBG uptake via the serotonin transporter located on megakaryocytes
Laquinimod ameliorates excitotoxic damage by regulating glutamate re-uptake
Neuroblastoma : mIBG in its diagnosis and management
Selective serotonin re-uptake inhibitor sertraline inhibits bone healing in a calvarial defect model
MYCN-driven fatty acid uptake is a metabolic vulnerability in neuroblastoma
Selective serotonin re-uptake inhibitors and the risk of violent suicide: a nationwide postmortem study
LRP8‐mediated selenocysteine uptake is a targetable vulnerability in MYCN‐amplified neuroblastoma
A sexually dimorphic hepatic cycle of periportal VLDL generation and subsequent pericentral VLDLR-mediated re-uptake
Bilateral adrenal uptake of 123I MIBG scintigraphy with mild catecholamine elevation, the diagnostic dilemma, and its characteristics
Molecular studies of ligand binding properties and re-uptake mechanisms at the human and murine serotonin transporter
Myokardialer I-123-Metajodbenzylguanidin (MIBG) Uptake als Zeichen der sympathischen Reinnervation nach Herztransplantation : eine Doppelnuklidstudie mit Thallium-201
123I metaiodobenzylguanidine (MIBG) uptake predicts early relapse of neuroblastoma using semi-quantitative SPECT/CT analysis
Thrombocytopenia after meta-iodobenzylguanidine (MIBG) therapy in neuroblastoma patients may be caused by selective MIBG uptake via the serotonin transporter located on megakaryocytes
Laquinimod ameliorates excitotoxic damage by regulating glutamate re-uptake
Neuroblastoma : mIBG in its diagnosis and management
Selective serotonin re-uptake inhibitor sertraline inhibits bone healing in a calvarial defect model
MYCN-driven fatty acid uptake is a metabolic vulnerability in neuroblastoma
Selective serotonin re-uptake inhibitors and the risk of violent suicide: a nationwide postmortem study
LRP8‐mediated selenocysteine uptake is a targetable vulnerability in MYCN‐amplified neuroblastoma
A sexually dimorphic hepatic cycle of periportal VLDL generation and subsequent pericentral VLDLR-mediated re-uptake
Bilateral adrenal uptake of 123I MIBG scintigraphy with mild catecholamine elevation, the diagnostic dilemma, and its characteristics
Molecular studies of ligand binding properties and re-uptake mechanisms at the human and murine serotonin transporter